Webinar
Webinar: A new automated potency analysis technique for suspension cells
25 November 2024
Cellply selected as finalist at Lyfebulb Oncology Award
News
Cellply selected as finalist at Lyfebulb Oncology Award
MONACO, PRINCIPALITY OF MONACO, NEW YORK, NY, and BOLOGNA, ITALY, March 1, 2018:
Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, with activities focused on early-stage investments in areas of high unmet patient need, have announced today that Cellply has been selected as one the eleven finalist companies for the Lyfebulb-Helsinn Innovation Summit & Award in Oncology. The Lyfebulb-Helsinn Innovation Summit & Award final event will be hosted on 26-27 March 2018, by Lyfebulb and Helsinn at the Monte-Carlo Bay Hotel and Resort, in Monaco, Principality of Monaco.
Read the full story here
continue reading
You may also like
Events
Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups
6 November 2024
Events
Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique at SITC 39th Annual Meeting
31 October 2024
Webinar
Webinar: Uncovering hidden immune cell killing to understand anti-tumor activity
2 October 2024
Webinar
Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte
9 September 2024
News
Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation
29 August 2024
Webinar
Webinar: Rapid single cell functional characterization for cell therapy potency
12 July 2024
News
Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco
23 May 2024
Events
Advancing TCR-based Cell Therapies & Bispecific Approaches
24 April 2024
Press release
Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development
19 March 2024
Events
Dual attendance for Cellply at March’s leading events in the cell therapy industry.
18 March 2024
Events
Launch of VivaCyte® at Advanced Therapies Week 2024
26 January 2024
News
Cellply launches its end-to-end single cell potency characterization platform VivaCyte
17 January 2024
Events
Cellply at Advanced Therapies Week 2024
4 January 2024
News
Cellply – Fesr programme 2021-2027
28 December 2023
Press release
Cellply concludes a new internal round of €3.6 million and extends the round to new investors!
27 September 2023
News
CellPly announces acceptance of one abstract at the CICON23 conference
18 September 2023
Press release
CellPly announces Emiliano Spagnolo as the new CEO
27 July 2023
News
L’innovazione Cellply in un articolo sulla rivista Le Scienze
4 March 2020
Events
Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting
25 November 2019
News
Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize
22 November 2018
Events
Cellply invited to present at the World Health Summit 2019
22 October 2018
Events
Cellply abstract accepted at the AACR 2018 Annual Meeting
4 February 2018
Press release
Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting
4 November 2016
News
Cellply wins an H2020 SME Instrument Phase 1 grant
20 October 2016
Keep in touch
Need some infos?
Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.